Groenendijk, Floris H <br/><br/>
Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.  [electronic resource] 

 -  European urology  Aug 2015 
 - e33-4 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2015.02.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Mutation<br/>Neoadjuvant Therapy<br/>Urinary Bladder Neoplasms